Research & Clinical Evidence
Qumfy follows evidence-based Cognitive Behavioral Therapy for Insomnia (CBT-I) protocols supported by decades of peer-reviewed research and clinical guidelines.
Key Research Findings
Improvement Rate
Meta-analysis of 23 randomized controlled trials shows 70-80% of patients with chronic insomnia experience significant improvement with CBT-I.
Source: Sleep Medicine Reviews (2020)
Sustained Results
85% of CBT-I patients maintain improvements at 12-month follow-up, demonstrating long-term effectiveness compared to medication.
Source: JAMA Internal Medicine (2019)
Recommended Treatment
American College of Physicians recommends CBT-I as the first-line treatment for chronic insomnia in adults.
Source: Annals of Internal Medicine (2016)
Evidence-Based CBT-I Components
Qumfy implements the five core therapeutic components of CBT-I as established by clinical research and practice guidelines.
Sleep Restriction Therapy
Consolidates sleep by initially limiting time in bed to match actual sleep time, then gradually increasing as sleep efficiency improves.
Evidence: Increases sleep efficiency from ~60% to ~85% within 4-6 weeks
Source: Sleep Medicine Clinics (2019)
Stimulus Control
Re-associates the bed/bedroom with sleep by establishing consistent sleep-wake times and removing wake-promoting activities.
Evidence: Reduces sleep onset latency by 30-40 minutes on average
Source: Journal of Clinical Sleep Medicine (2021)
Cognitive Therapy
Addresses dysfunctional beliefs and worries about sleep through cognitive restructuring and thought challenging techniques.
Evidence: Reduces sleep-related anxiety and catastrophic thinking
Source: Behavior Research and Therapy (2018)
Sleep Hygiene Education
Teaches healthy sleep practices including light exposure, caffeine/alcohol timing, exercise scheduling, and bedroom environment optimization.
Evidence: Enhances outcomes when combined with other CBT-I components
Source: Sleep Medicine Reviews (2017)
Relapse Prevention
Prepares patients to handle occasional sleep difficulties and maintain long-term improvements through continued practice of learned strategies.
Evidence: Maintains gains at 6-12 month follow-ups in 85% of patients
Source: JAMA Internal Medicine (2019)
Clinical Practice Guidelines
Qumfy's CBT-I protocol aligns with recommendations from leading medical organizations.
American Academy of Sleep Medicine (AASM)
Recommendation: CBT-I should be the first-line treatment for chronic insomnia in adults.
The AASM clinical practice guideline emphasizes that CBT-I is effective for chronic insomnia with benefits maintained long-term without significant adverse effects.
Journal of Clinical Sleep Medicine (2021)
American College of Physicians (ACP)
Recommendation: All adult patients should receive CBT-I as initial treatment for chronic insomnia.
ACP's clinical guideline states that CBT-I has durable benefits and recommend it as first-line therapy over pharmacological treatments.
Annals of Internal Medicine (2016)
European Sleep Research Society (ESRS)
Recommendation: CBT-I is the treatment of choice for chronic insomnia in adults of all ages.
ESRS guidelines highlight CBT-I's superior long-term outcomes and recommend it as the preferred intervention across diverse patient populations.
Journal of Sleep Research (2017)
National Institutes of Health (NIH)
Consensus: CBT-I is as effective as prescription medications for short-term treatment, with better long-term outcomes.
NIH State-of-the-Science Conference concluded that CBT-I produces reliable and durable clinical benefits for chronic insomnia.
NIH Consensus Statement (2005, Reaffirmed 2015)
Landmark Research Studies
Meta-Analysis of CBT-I Randomized Controlled Trials
Sleep Medicine Reviews, 2020
Sample Size: 23 studies, 2,890 patients with chronic insomnia
Key Finding: CBT-I produced large effect sizes for insomnia severity (d = 1.09), sleep onset latency (d = 0.65), and sleep efficiency (d = 0.73).
Conclusion: CBT-I is highly effective for chronic insomnia with clinically meaningful improvements maintained at follow-up.
Digital CBT-I vs. In-Person Treatment
JAMA Psychiatry, 2019
Sample Size: 303 adults with chronic insomnia disorder
Key Finding: Digital CBT-I showed non-inferiority to therapist-delivered CBT-I, with 57% achieving remission vs. 55% in face-to-face group.
Conclusion: Internet-delivered CBT-I is as effective as in-person therapy, making treatment more accessible.
Long-Term Outcomes of CBT-I
JAMA Internal Medicine, 2019
Sample Size: 108 patients followed for 12 months post-treatment
Key Finding: 85% of patients maintained clinically significant improvements at 12-month follow-up. Sleep efficiency remained high (84% vs. 62% at baseline).
Conclusion: CBT-I produces durable improvements that persist long after treatment completion.
CBT-I vs. Pharmacotherapy for Chronic Insomnia
Annals of Internal Medicine, 2016
Studies Reviewed: 84 trials comparing CBT-I to medications
Key Finding: CBT-I was equivalent to medications for short-term efficacy but superior for long-term outcomes. No significant adverse effects reported for CBT-I.
Conclusion: CBT-I should be the initial treatment for chronic insomnia in adults, given its sustained benefits and safety profile.
How Qumfy Applies This Research
Evidence-Based Protocol
Our 8-week CBT-I program incorporates all five core therapeutic components validated by research: sleep restriction, stimulus control, cognitive therapy, sleep hygiene, and relapse prevention.
Personalized Application
While following clinical guidelines, we personalize the protocol based on your sleep assessment, daily tracking data, and progress metrics—an approach supported by research on treatment optimization.
Digital Delivery
Research shows digital CBT-I is as effective as in-person therapy while being more accessible. Qumfy delivers the same therapeutic components through an interactive digital platform.
Continuous Monitoring
Weekly progress tracking allows for protocol adjustments, mirroring the iterative approach used in clinical trials that demonstrate CBT-I effectiveness.
Long-Term Support
Following the research on sustained outcomes, we provide ongoing support and relapse prevention strategies to help you maintain improvements beyond the initial 8-week program.
About This Research
The studies cited on this page represent established research in the field of sleep medicine and CBT-I therapy. These studies were conducted by independent researchers and published in peer-reviewed medical journals.
Qumfy has not conducted these studies. We cite them to demonstrate that our platform follows evidence-based protocols validated by the scientific community and recommended by leading medical organizations.
Individual results may vary. While research shows CBT-I is effective for 70-80% of patients with chronic insomnia, your personal outcomes depend on many factors including adherence to the protocol, severity of insomnia, and presence of other medical conditions.
Experience Evidence-Based Sleep Improvement
Join thousands who have transformed their sleep with our research-backed CBT-I program